Newport Huntington Medical Group

Huntington Beach, California 92648

2 studies enrolling now · 12 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Arthritis, Juvenile, Arthritis, Psoriatic, Arthritis, Rheumatoid, Autoimmune Diseases, Connective Tissue Diseases, Crohn's Disease, Immune System Diseases, Joint Diseases, Juvenile Psoriatic Arthritis, Musculoskeletal Diseases

Studies at this site

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis — Recruiting now
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) — Recruiting now
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent — Running, not enrolling
• A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis — Stopped early
• An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis — Completed
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis — Completed
• A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis — Completed
• ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis — Stopped early